335 related articles for article (PubMed ID: 9973212)
1. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; Sun D; Windle BE; Hurley LH; Von Hoff DD
Cancer Res; 1999 Feb; 59(3):639-44. PubMed ID: 9973212
[TBL] [Abstract][Full Text] [Related]
2. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
[TBL] [Abstract][Full Text] [Related]
3. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
5. Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos.
Izbicka E; Nishioka D; Marcell V; Raymond E; Davidson KK; Lawrence RA; Wheelhouse RT; Hurley LH; Wu RS; Von Hoff DD
Anticancer Drug Des; 1999 Aug; 14(4):355-65. PubMed ID: 10625928
[TBL] [Abstract][Full Text] [Related]
6. Affinity and selectivity of G4 ligands measured by FRET.
De Cian A; Guittat L; Shin-ya K; Riou JF; Mergny JL
Nucleic Acids Symp Ser (Oxf); 2005; (49):235-6. PubMed ID: 17150720
[TBL] [Abstract][Full Text] [Related]
7. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
[TBL] [Abstract][Full Text] [Related]
9. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase.
Perry PJ; Read MA; Davies RT; Gowan SM; Reszka AP; Wood AA; Kelland LR; Neidle S
J Med Chem; 1999 Jul; 42(14):2679-84. PubMed ID: 10411488
[TBL] [Abstract][Full Text] [Related]
10. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
[TBL] [Abstract][Full Text] [Related]
11. Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation.
Moore MJ; Schultes CM; Cuesta J; Cuenca F; Gunaratnam M; Tanious FA; Wilson WD; Neidle S
J Med Chem; 2006 Jan; 49(2):582-99. PubMed ID: 16420044
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors.
Read M; Harrison RJ; Romagnoli B; Tanious FA; Gowan SH; Reszka AP; Wilson WD; Kelland LR; Neidle S
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4844-9. PubMed ID: 11309493
[TBL] [Abstract][Full Text] [Related]
14. Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines.
Zhou JM; Zhu XF; Lu YJ; Deng R; Huang ZS; Mei YP; Wang Y; Huang WL; Liu ZC; Gu LQ; Zeng YX
Oncogene; 2006 Jan; 25(4):503-11. PubMed ID: 16170347
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines.
Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716
[TBL] [Abstract][Full Text] [Related]
16. Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase.
Shi DF; Wheelhouse RT; Sun D; Hurley LH
J Med Chem; 2001 Dec; 44(26):4509-23. PubMed ID: 11741471
[TBL] [Abstract][Full Text] [Related]
17. In vitro assays predictive of telomerase inhibitory effect of G-quadruplex ligands in cell nuclei.
Yaku H; Murashima T; Miyoshi D; Sugimoto N
J Phys Chem B; 2014 Mar; 118(10):2605-14. PubMed ID: 24328194
[TBL] [Abstract][Full Text] [Related]
18. Binding of G-quadruplex-interactive agents to distinct G-quadruplexes induces different biological effects in MiaPaCa cells.
Liu W; Sun D; Hurley LH
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1801-15. PubMed ID: 16438049
[TBL] [Abstract][Full Text] [Related]
19. Pyridyl-substituted corrole isomers: synthesis and their regulation to G-quadruplex structures.
Ma H; Zhang M; Zhang D; Huang R; Zhao Y; Yang H; Liu Y; Weng X; Zhou Y; Deng M; Xu L; Zhou X
Chem Asian J; 2010 Jan; 5(1):114-22. PubMed ID: 19937863
[TBL] [Abstract][Full Text] [Related]
20. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Shammas MA; Shmookler Reis RJ; Akiyama M; Koley H; Chauhan D; Hideshima T; Goyal RK; Hurley LH; Anderson KC; Munshi NC
Mol Cancer Ther; 2003 Sep; 2(9):825-33. PubMed ID: 14555701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
